Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi

  • Francesco Zaja, Flavia Salvi, Maura Rossi, Elena Sabattini, Andrea Evangelista, Giovannino Ciccone, Emanuele Angelucci, Gianluca Gaidano, Manuela Zanni, Marco Ladetto, Annalisa Chiappella, Umberto Vitolo, Pier Luigi Zinzani, Catello Califano, Alessandra Tucci, Caterina Patti, Stefano A. Pileri, Valentina Lenti, Pier Paolo Piccaluga, Federica Cavallo, Stefano Volpetti, Giulia Perali, Sarit Assouline, Koren Kathleen Mann, Ryan Morin, Miguel Alcaide, Kevin Bushell, Renato Fanin, Alessandro Levis
  • Leukemia & Lymphoma, April 2018, Taylor & Francis
  • DOI: 10.1080/10428194.2018.1452208

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1080/10428194.2018.1452208